Teva Announces FDA Response to Citizen Petition (Business Wire via Yahoo! Finance)
JERUSALEM----Teva Pharmaceutical Industries Ltd. today announced that the Food and Drug Administration has responded to their Citizen Petition regarding COPAXONE . The FDA declined to review the CP "without comment on the approvability of any Abbreviated New Drug Application or New Drug Application for a glatiramer acetate injection drug product because it would be premature and inappropriate ...

Lilly's Symbyax gets US FDA approval for resistant depression (PharmaBiz)
The US Food and Drug Administration (FDA) has approved a new indication for Symbyax (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company announced. Symbyax is now the first drug approved by the FDA for the acute treatment of treatment-resistant depression (TRD).

Lautenberg Urges FDA To Remove Electronic Cigarettes From The Market Until Proven Safe (Medical News Today)
Sen. Frank R. Lautenberg (D-NJ) urged the Food and Drug Administration (FDA) to take electronic cigarettes, or "e-cigarettes," off the market until they are proven safe by the federal agency. Electronic cigarettes, alternatives to cigarettes and other tobacco products, are battery-powered devices that use a vapor to deliver nicotine to smokers.